PSMA scan-guided salvage radiation after prostate surgery
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether using a specialized PSMA PET scan to guide radiation can better treat prostate cancer that returns after prostate surgery. It targets the “prostate bed” area with a shorter, stronger radiation schedule (hypofractionated) to control rising PSA levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had prostate surgery (radical prostatectomy) already
- Your cancer has no spread to lymph nodes or distant organs based on a recent PSMA PET scan done within 60 days
- Your PSA has been rising after surgery in a specific pattern, and your current PSA is under 1.0
- You are in good enough health to do daily activities (WHO performance status 0 to 2)
- You are between 18 and 80 years old and can sign consent and complete quality-of-life questionnaires
- You have not had pelvic radiation, and you have not had hormone therapy, chemotherapy, or orchiectomy before starting this trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a precise type of radiation (called SBRT) to the prostate bed for men whose PSA starts rising after prostate removal surgery. It aims to see if this targeted approach can effectively treat the recurrence without needing long-term hormone therapy.
This trial uses a special scan (PSMA-PET) to find where prostate cancer has returned after surgery. Then doctors give a lower dose of radiation only to that area, which may reduce side effects. It is for men whose PSA level is rising after prostate removal.
This trial uses a special PET/MR scan to help doctors aim stereotactic radiation more precisely for certain higher-risk or unfavorable intermediate prostate cancers. It studies whether this targeted approach can safely treat the prostate (and specific areas needing extra treatment) without spreading to the body.
This trial studies whether a targeted scan (PSMA PET/CT) can help doctors choose the best “salvage” radiation treatment when prostate cancer comes back by PSA blood tests after surgery. It may help some people avoid under- or over-treating the areas where the cancer is returning.
This trial tests whether a special scan (PSMA PET) can help doctors aim and adjust radiation more precisely when prostate cancer returns after surgery. It may help by increasing dose to areas that look involved while lowering dose to uninvolved pelvic areas.
This study tests an “early salvage” approach using radiotherapy after prostate cancer surgery when PSA starts rising again. It aims to see whether earlier treatment (chosen based on higher-risk features) can improve outcomes for people who did not take immediate extra therapy after surgery.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.